search
Back to results

Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)

Primary Purpose

Ichthyosis Inherited

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Cutaneous wraps
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ichthyosis Inherited focused on measuring Ichthyosis, inherited, wraps, skin scales, cutaneous abnormalities

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient with hereditary ichthyosis regardless of the clinical form Patient with a scaling or erythema score > 6/16 Patient with a skin discomfort score > 3/10 Patient having given written, free and informed consent Patient affiliated to a social security scheme Exclusion Criteria: Patient with a skin disease other than ichthyosis Patient having modified his treatments for ichthyosis in the month preceding inclusion Patient with known intolerance or allergy to one of the topicals used in the study Patient unable to complete the study questionnaires Patient under a protection regime

Sites / Locations

  • Toulouse University hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Wraps (body and feet) as well as scalp care

Arm Description

The skin care consisting of wraps (body and feet) and scalp care, will be carried out consecutively over 3 days, in the hospital (outpatient or in day/traditional hospitalization).

Outcomes

Primary Outcome Measures

Skin discomfort Analogue Visual Scale (AVS)
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the AVS scale (0-10) of cutaneous discomfort between baseline and 11 days after treatment

Secondary Outcome Measures

Reduction of skin discomfort - day 4
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the Analogue Visual Scale (AVS) (0-10) of cutaneous discomfort between baseline and day 4
Reduction of skin discomfort - day 30
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the Analogue Visual Scale (AVS) (0-10) of cutaneous discomfort between baseline and day 30
Variation of erythema and scales severity - VIIS
Variation of erythema and scales severity judged by : - Their intensity, measured with the Visual Index for Ichthyosis Severity (VIIS)
Variation of erythema and scales severity
Variation of erythema and scales severity judged by : -Their extent, measured with the scores A and B of the Specific Clinical Ichthyosis Score
Cutaneous pain - day 4
Variation of pain assessed by the Analogue Visual Scale (0-10) of skin pain
pruritus - day 4
Variation of pruritus assessed by the Analogue Visual Scale (0-10)
sweating - day 4
Variation of sweating assessed by the Analogue Visual Scale (0-10)
Cutaneous pain - day 11
Variation of pain assessed by the Analogue Visual scale (0-10) of skin pain
pruritus - day 11
Variation of pruritus assessed by the Analogue Visual scale (0-10)
sweating - day 11
Variation of sweating assessed by the Analogue Visual Scale scale (0-10)
Cutaneous pain - day 30
Variation of pain assessed by the Analogue Visual Scale (0-10) of skin pain
pruritus - day 30
Variation of pruritus assessed by the Analogue Visual Scale scale (0-10)
sweating - day 30
Variation of sweating assessed by the Analogue Visual Scale (0-10)
Feet and scalp discomfort - day 4
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
Feet and scalp discomfort - day 11
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
Feet and scalp discomfort - day 30
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
32-item Ichthyosis Quality of Life questionnaire (IQoL-32)
Variation of patient's quality of life, measured by the ichthyosis specific quality of life questionnaire (IQoL-32)

Full Information

First Posted
July 28, 2023
Last Updated
July 28, 2023
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT05979506
Brief Title
Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
Official Title
Evaluate the Evolution of Cutaneous Discomfort of the Body and Scalp After 3 Wraps, in Patients With Moderate to Very Severe Hereditary Ichthyosis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
April 1, 2025 (Anticipated)
Study Completion Date
April 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Ichthyosis is a group of rare and chronic genetic diseases beginning at birth, in which the patient's skin is covered with scales of variable appearance and severity. This disease is disabling, in particular due to sensations of pruritus, skin pain and the possible presence of associated extra-cutaneous abnormalities. The treatment is symptomatic and is based on the daily application of moisturizing creams with a high lipid content for better effectiveness, keratolytic creams, and for severe forms, oral retinoids may be necessary. Nevertheless, the effectiveness of these treatments is limited and are considered very painful by the patients. Wraps are local treatments carried out by specialized nurses and which consist in, following a therapeutic bath, applying a large quantity of cream to the whole body, followed by an occlusion. This type of care is simple to perform, but requires nursing expertise, to date, it is not carried out in standard practice in France, which is why we wish to evaluate the effect of wraps on different parameters reflecting the skin condition in the short and medium term.
Detailed Description
Ichthyosis is a group of rare and chronic genetic diseases beginning at birth, in which the patient's skin is covered with scales of variable appearance and severity. There are 2 distinct typical profiles: patients with thick scales without erythroderma and patients with finer scales on an erythrodermic background. This disease is disabling, in particular due to sensations of pruritus, skin pain and the possible presence of associated extra-cutaneous abnormalities. The treatment is symptomatic and is based on the daily application of moisturizing creams with a high lipid content for better effectiveness, keratolytic creams, and for severe forms, oral retinoids may be necessary. The creams improve the condition of the skin and reduce the sensations of skin discomfort, pain and pruritus, nevertheless, the effectiveness of these treatments is limited and are considered very painful by the patients. Wraps are local treatments carried out by specialized nurses and which consist in, following a therapeutic bath, applying a large quantity of cream to the whole body, followed by an occlusion. The type of cream is adapted to the area of application: thus, an emollient cream is used for the body; a cream enriched with keratolytic active ingredients is used for the feet in the event of hyperkeratosis, and an emollient cream possibly enriched with keratolytic active ingredients is used for the scalp, followed by an exposure time under a steam helmet to remove scales. This type of care is simple to perform, but requires nursing expertise, to date, it is not carried out in standard practice in France, except in the centers of Toulouse, Bordeaux and Necker and at the thermal cure of Avène-les-Bains. However, the interest of such a treatment has never been evaluated independently, which is why in this study we want to evaluate the effect of carrying out a daily treatment (including a therapeutic bath, a wrap (body and feet) and scalp care) over 3 consecutive days, on different parameters reflecting the skin condition in the short and medium term

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ichthyosis Inherited
Keywords
Ichthyosis, inherited, wraps, skin scales, cutaneous abnormalities

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Interventional, prospective, multicenter (Toulouse - Bordeaux - Paris Necker), comparative (baseline vs. short and medium term)
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Wraps (body and feet) as well as scalp care
Arm Type
Experimental
Arm Description
The skin care consisting of wraps (body and feet) and scalp care, will be carried out consecutively over 3 days, in the hospital (outpatient or in day/traditional hospitalization).
Intervention Type
Procedure
Intervention Name(s)
Cutaneous wraps
Intervention Description
The topical treatment that will be used in this study are: For the body, an emollient cream with a high lipid content: Cold cream For the scalp and feet, an emollient preparation with keratolytic action: 10% or 30% urea, depending on the scalp and feet damage Each of the 3 treatments (body, scalp and feet) will be carried out as follows: Application of different topicals all over the body and face, after taking a lukewarm therapeutic bath of 20 minutes Occlusion by "wrapping" the patient in a plastic film, then covering with a blanket After 1 hour, the unabsorbed excess cream is removed with a towel
Primary Outcome Measure Information:
Title
Skin discomfort Analogue Visual Scale (AVS)
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the AVS scale (0-10) of cutaneous discomfort between baseline and 11 days after treatment
Time Frame
day 11
Secondary Outcome Measure Information:
Title
Reduction of skin discomfort - day 4
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the Analogue Visual Scale (AVS) (0-10) of cutaneous discomfort between baseline and day 4
Time Frame
day 4
Title
Reduction of skin discomfort - day 30
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the entire body, measured with the Analogue Visual Scale (AVS) (0-10) of cutaneous discomfort between baseline and day 30
Time Frame
day 30
Title
Variation of erythema and scales severity - VIIS
Description
Variation of erythema and scales severity judged by : - Their intensity, measured with the Visual Index for Ichthyosis Severity (VIIS)
Time Frame
day 4
Title
Variation of erythema and scales severity
Description
Variation of erythema and scales severity judged by : -Their extent, measured with the scores A and B of the Specific Clinical Ichthyosis Score
Time Frame
day 4
Title
Cutaneous pain - day 4
Description
Variation of pain assessed by the Analogue Visual Scale (0-10) of skin pain
Time Frame
day 4
Title
pruritus - day 4
Description
Variation of pruritus assessed by the Analogue Visual Scale (0-10)
Time Frame
day 4
Title
sweating - day 4
Description
Variation of sweating assessed by the Analogue Visual Scale (0-10)
Time Frame
day 4
Title
Cutaneous pain - day 11
Description
Variation of pain assessed by the Analogue Visual scale (0-10) of skin pain
Time Frame
day 11
Title
pruritus - day 11
Description
Variation of pruritus assessed by the Analogue Visual scale (0-10)
Time Frame
day 11
Title
sweating - day 11
Description
Variation of sweating assessed by the Analogue Visual Scale scale (0-10)
Time Frame
day 11
Title
Cutaneous pain - day 30
Description
Variation of pain assessed by the Analogue Visual Scale (0-10) of skin pain
Time Frame
day 30
Title
pruritus - day 30
Description
Variation of pruritus assessed by the Analogue Visual Scale scale (0-10)
Time Frame
day 30
Title
sweating - day 30
Description
Variation of sweating assessed by the Analogue Visual Scale (0-10)
Time Frame
day 30
Title
Feet and scalp discomfort - day 4
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
Time Frame
day 4
Title
Feet and scalp discomfort - day 11
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
Time Frame
day 11
Title
Feet and scalp discomfort - day 30
Description
Percentage of patients showing a reduction of at least 3 points of their skin discomfort in the feet and scalp, measured with the Analogue Visual Scale (0-10) of cutaneous discomfort
Time Frame
day 30
Title
32-item Ichthyosis Quality of Life questionnaire (IQoL-32)
Description
Variation of patient's quality of life, measured by the ichthyosis specific quality of life questionnaire (IQoL-32)
Time Frame
30 days after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with hereditary ichthyosis regardless of the clinical form Patient with a scaling or erythema score > 6/16 Patient with a skin discomfort score > 3/10 Patient having given written, free and informed consent Patient affiliated to a social security scheme Exclusion Criteria: Patient with a skin disease other than ichthyosis Patient having modified his treatments for ichthyosis in the month preceding inclusion Patient with known intolerance or allergy to one of the topicals used in the study Patient unable to complete the study questionnaires Patient under a protection regime
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anne-Marie TRANIER
Phone
05 67 77 14 57
Email
tranier.am@chu-toulouse.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne-Marie TRANIER
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
Toulouse University hospital
City
Toulouse
ZIP/Postal Code
31059
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne-Marie TRANIER
Phone
0567771457
Email
tranier.am@chu-toulouse.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)

We'll reach out to this number within 24 hrs